Health Care & Life Sciences » Pharmaceuticals | Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc. | Income Statement

Fiscal year is October-September. All values USD Thousands.
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
-
-
1.30
2.60
1.80
Gross Income
-
-
1.30
2.60
1.80
SG&A Expense
869.60
3,229.90
7,447.90
9,983.70
13,430
EBIT
869.60
3,229.90
7,449.30
9,986.30
13,431.70
Unusual Expense
-
332.10
838.20
452.10
92.60
Non Operating Income/Expense
11.40
-
-
-
818.30
Interest Expense
123.80
7.50
9.00
850.80
15.80
Pretax Income
981.20
2,902.30
8,295.70
10,385.00
12,536.60
Consolidated Net Income
981.20
2,902.30
8,295.70
10,385.00
12,536.60
Net Income
981.20
2,902.30
8,295.70
10,385.00
12,536.60
Net Income After Extraordinaries
981.20
2,902.30
8,295.70
10,385.00
12,536.60
Net Income Available to Common
981.20
2,902.30
8,295.70
10,385.00
12,536.60
EPS (Basic)
0.75
1.35
2.25
1.89
1.17
Basic Shares Outstanding
1,288.10
2,122.40
3,623.20
5,482.50
10,731.90
EPS (Diluted)
0.76
1.37
2.29
1.89
1.17
Diluted Shares Outstanding
1,288.10
2,122.40
3,623.20
5,482.50
10,731.90
EBITDA
869.60
-
7,448.00
9,983.70
13,430
Non-Operating Interest Income
0.70
3.10
0.80
-
-

About Citius Pharmaceuticals

View Profile
Address
11 Commerce Drive
Cranford New Jersey 07016
United States
Employees -
Website http://www.citiuspharma.com
Updated 07/08/2019
Citius Pharmaceuticals, Inc. engages in the development and commercialization of therapeutic products. Its products include Mino-Lok and hydrocortisone-lidocaine. The company was founded on September 09, 2010 and is headquartered in Cranford, NJ.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.